化合物 T11056 T11056
面议
- TargetMol
- 生产商
- 进口
- 美国
- 现货
- 全国
- 6
- 1
Product IntroductionBioactivity英文名: DLK-IN-1描述: DLK-IN-1 is a selective oral active inhibitor of bisleucine zipper kinase
AI问答
配套的仪器设备？
可以搭配的相关耗材试剂？
耗材描述
Product Introduction
Bioactivity
英文名: DLK-IN-1
描述: DLK-IN-1 is a selective oral active inhibitor of bisleucine zipper kinase (DLK, MAP3K12) with Ki of 3 nM. DLK-IN-1 is active in the Alzheimer's disease model, retains excellent CNS permeability, and after multiple days of administration, its concentration exceeds the concentration required for DLK inhibition in the brain, so it has good tolerance Acceptability.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 62.5 mg/mL (147.60 mM)
关键字: DLK IN 1 | DLK-IN-1 | DLKIN1
相关产品: CEP-40125 | Miriplatin hydrate | Carmustine | Streptozocin | Palifosfamide | Tretazicar | URMC-099 | VAL-083 | Seco-Duocarmycin SA | Satraplatin
Bioactivity
英文名: DLK-IN-1
描述: DLK-IN-1 is a selective oral active inhibitor of bisleucine zipper kinase (DLK, MAP3K12) with Ki of 3 nM. DLK-IN-1 is active in the Alzheimer's disease model, retains excellent CNS permeability, and after multiple days of administration, its concentration exceeds the concentration required for DLK inhibition in the brain, so it has good tolerance Acceptability.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 62.5 mg/mL (147.60 mM)
关键字: DLK IN 1 | DLK-IN-1 | DLKIN1
相关产品: CEP-40125 | Miriplatin hydrate | Carmustine | Streptozocin | Palifosfamide | Tretazicar | URMC-099 | VAL-083 | Seco-Duocarmycin SA | Satraplatin
猜你喜欢
感兴趣产品